Carregant...
Combination therapy with corticosteroid and mycophenolate mofetil in a case of refractory cardiac sarcoidosis
Management of cardiac sarcoidosis (CS) can be challenging. The first-line therapy for this condition is corticosteroids, but other immunosuppressive agents are sometimes co-administered to reduce the dosage of corticosteroid and to thereby avoid steroid-induced adverse effects or to increase its the...
Guardat en:
| Publicat a: | J Cardiol Cases |
|---|---|
| Autors principals: | , , , , , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Japanese College of Cardiology
2016
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6280734/ https://ncbi.nlm.nih.gov/pubmed/30546624 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jccase.2015.12.008 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|